← All trials
NCT03758079
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2018
- Primary completion
- Oct 8, 2018
- Completion date
- Oct 8, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 14
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of BalamandLead sponsor
- University of BalamandOverall official - principal investigator
- University of BalamandReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.